How do I make a difference?
It's a rare day that I don't pick up the phone and hear the hopeful voice of a patient or physician looking for answers. Working for the gold standard in diagnostics, I know our tests will provide the clarity they need and the potential to avoid surgery. I am grateful to be here making a difference.
Real People,
Real Science,
Real Answers.
NITASHA PRASAD
Client Services Specialist
Veracyte
This is the Age of Evidence.
Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.

Veracyte gives patients a clearer path for the future.

We are leading in the Age of Evidence.
our impact
The Age
of Evidence
Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.
Learn More >
Highlighted by National Cancer Institute
NCI highlights lung cancer early detection work behind Percepta in its annual plan
learn more >
Answers That Set New Standards
Veracyte’s CEO named as one of 2017’s Fiercest Women in Life Sciences

learn more >


latest news
news and updates
Jan 8, 2018
Veracyte Announces Strategic Realignment and New Appointments to Advance Commercial Growth

learn more >
Dec 4, 2017
Veracyte’s CEO Named as one of 2017’s Fiercest Women in Life Sciences

learn more >
Nov 28, 2017
Veracyte Announces Publication of Data Confirming Analytical Validity of Envisia Genomic Classifier for Use in IPF Diagnosis

learn more >